3336-41-2|3,5-Dichloro-4-hydroxybenzoic acid

Current Location
Home Products
detail

3,5-Dichloro-4-hydroxybenzoic acid | CAS:3336-41-2

3,5-Dichloro-4-hydroxybenzoic acid

Name：3,5-Dichloro-4-hydroxybenzoic acid
CAS：3336-41-2
Synonyms：
Molecular Formula：C₇H₄Cl₂O₃
Molecular Weight：207.01
EINESC：222-071-9

Description

Properties

Melting point	260-265 ºC

Safety

Symbol(GHS)	Xi
Hazard Codes	R36/37/38
SDS/MSDS	S26;S37/39

SDS

Source	SDS/MSDS Samples
Alfa-Aesar	View & Download
Sigma-Aldrich	View & Download
TCI	View & Download

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

PKCα Deficiency in Mice Is Associated with Pulmonary Vascular Hyperresponsiveness to Thromboxane A2 and Increased Thromboxane Receptor Expression.Christoph Tabeling et al.Journal of vascular research, 52(4), 279-288 (2016-02-20) New anti-tuberculosis agents amongst known drugs.Kathryn E A Lougheed et al.Tuberculosis (Edinburgh, Scotland), 89(5), 364-370 (2009-08-25) Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.Cecilia K Zetterström et al.Journal of leukocyte biology, 83(1), 31-38 (2007-10-05) Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin.Farivash Darabi et al.Journal of inorganic biochemistry, 149, 102-107 (2015-04-14) aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.Meghan Riddell et al.Nature communications, 9(1), 5357-5357 (2018-12-19)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News